Dihydroartemisinin attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting oxidative stress

Neonatal hypoxic-ischemic encephalopathy (HIE) induced by perinatal asphyxia is a major cause of neurological disability among infants. Dihydroartemisinin (DHA), derived from artemisinin, well known as an anti-malarial medicine, was proved to be able to inhibit oxidative stress and inflammation. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Qian, Li, Xiaohuan, Xia, Lei, Yao, Zhengyu, Shi, Xiuyu, Dong, Zhifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052669/
https://www.ncbi.nlm.nih.gov/pubmed/35484595
http://dx.doi.org/10.1186/s13041-022-00921-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052669/
https://www.ncbi.nlm.nih.gov/pubmed/35484595
http://dx.doi.org/10.1186/s13041-022-00921-y

Ejemplares similares